Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis

Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis

Leishmaniasis, as a tropical and subtropical disease, is endemic in more than 90 countries around the world. Today, cutaneous leishmaniasis (CL) that affects more than 1.5 million people per year lacks a definitive treatment approach. Imatinib is an anticancer drug that inhibits the abnormal functio...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Mohsen Moslehi, Fatemeh Namdar, Mahsa Esmaeilifallah, Fariba Iraji, Bahareh Vakili, Fatemeh Sokhanvari, Seyed-Mohsen Hosseini, Faham Khamesipour, Zahra Sebghatollahi, Sayed-Hossein Hejazi
Formaat: Artikel
Taal:English
Gepubliceerd in: AIMS Press 2020-07-01
Reeks:AIMS Microbiology
Onderwerpen:
imatinib
cutaneous leishmaniasis
therapeutic
balb/c
Online toegang:https://www.aimspress.com/article/10.3934/microbiol.2020010/fulltext.html

Internet

https://www.aimspress.com/article/10.3934/microbiol.2020010/fulltext.html

Gelijkaardige items